Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
PolyPid Soars 3.4% on Pivotal FDA Endorsement for D-PLEX100 NDA
December 03, 2025
Via
MarketMinute
Tickers
PYPD
Exposures
Product Safety
Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results
December 03, 2025
Via
MarketMinute
Tickers
BMRN
CAPR
DYN
EWTX
INSM
PFE
Exposures
Product Safety
‘Pharma Bro’ Martin Shkreli Calls His Capricor Therapeutics Short A 'Bad Call' After DMD Trial Delivers Surprise Win
↗
December 03, 2025
Via
Stocktwits
Tickers
CAPR
Exposures
Product Safety
Precigen Stock Up 280% in a Year — Is FDA Approval Behind This Big New Investor Bet?
↗
December 02, 2025
Via
The Motley Fool
Tickers
PGEN
Exposures
Product Safety
Eli Lilly’s Jaypirca Granted Traditional FDA Approval In Treating Certain Cancers
↗
December 03, 2025
Via
Stocktwits
Tickers
DUHP
JGRO
LLY
Exposures
Product Safety
Incannex Healthcare Stock Soars 15% After FDA Fast Tracks Obstructive Sleep Apnea Drug
↗
December 03, 2025
Via
Stocktwits
Tickers
IXHL
Exposures
Product Safety
Rivian Recalls Nearly 35,000 Units Of Its Delivery Vans Over Seat Belt Pretensioner Wear-out Concerns
↗
December 03, 2025
Via
Stocktwits
Topics
Electric Vehicles
Product Recall
Tickers
ACES
AMZN
AVUS
DLTR
RIVN
Exposures
Electric Vehicles
Legal
Product Safety
Bristol Myers Stock Jumps As Wall Street Backs Added Enrollment In Alzheimer’s Trial — Retail Calls It ‘Worth A Play’
↗
December 03, 2025
Via
Stocktwits
Tickers
BMY
JPM
Exposures
Product Safety
AstraZeneca's Hard To Control Hypertension Drug Advances, With FDA Decision Expected In 2026
↗
December 03, 2025
Via
Benzinga
Exposures
Product Safety
More Than 1 Million Suicidal Depression Cases Per Year May Be Treated by 2030 via New Indication for Augmentation of Transcranial Magnetic Stimulation: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
December 03, 2025
Via
Get News
Tickers
NRXP
Exposures
Product Safety
From Shrimp To Shredded Cheese, America’s Packaged Food Recall Is Getting A Bit Chaotic — And Testing Shoppers’ Nerves
↗
December 03, 2025
Via
Stocktwits
Topics
Death
Product Recall
Tickers
COST
KR
PBJ
SPY
WMT
Exposures
Death
Legal
Product Safety
Is DexCom Stock Underperforming the S&P 500?
December 03, 2025
Via
Barchart.com
Topics
Economy
Stocks
World Trade
Exposures
Product Safety
Supply Chain
Tariff
Prediction: This Stock Has Soared Nearly 70% in 2025 and Will Be an Even Bigger Winner in 2026
↗
December 03, 2025
Via
The Motley Fool
Topics
Earnings
Tickers
MIRM
Exposures
Financial
Product Safety
Rivian To Recall 34,824 Vehicles After Seatbelt Failure Warning
↗
December 03, 2025
Via
Benzinga
Topics
Product Recall
Tickers
RIVN
Exposures
Legal
Product Safety
Don't Buy Summit Therapeutics Until This Big Thing Happen
↗
December 03, 2025
Via
The Motley Fool
Tickers
SMMT
Exposures
Product Safety
Rising Patient Interest in ‘Spravato Near Me’ Highlights Demand for Advanced Depression Treatment in Gilbert
December 03, 2025
Via
AB Newswire
Exposures
Product Safety
CCHR Florida Joins Global Call to Ban Electroshock Treatment, Citing New Evidence of Widespread Patient Harm
December 03, 2025
Via
24-7 Press Release
Topics
Product Recall
Exposures
Legal
Product Safety
Why Vera Therapeutics Stock Rocked the Market on Tuesday
↗
December 02, 2025
Via
The Motley Fool
Tickers
RJF
VERA
Exposures
Product Safety
FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
December 02, 2025
Via
PRLog
Exposures
Product Safety
Coach Todd Campbell Calls for Stronger Veteran Support: “We Can All Show Up”
December 02, 2025
Via
Get News
Topics
Product Recall
Exposures
Legal
Product Safety
AI-Assisted Ultrasounds Mark a New Era in Detecting Congenital Heart Defects
December 02, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Tickers
GOOGL
MSFT
NVDA
Exposures
Artificial Intelligence
Product Safety
FDA Takes Bold Leap into Agentic AI, Revolutionizing Healthcare Regulation
December 02, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Tickers
AMZN
GOOGL
MSFT
Exposures
Artificial Intelligence
Product Safety
CCHR: New Data Shows Millions of U.S. Children Caught in Escalating Psychiatric Polypharmacy
December 02, 2025
Via
PRLog
Exposures
Product Safety
Local Holistic Consultant Pharmacist Featured on National Podcast as FDA Updates Hormone Therapy Safety
December 02, 2025
Via
PRLog
Exposures
Product Safety
FDA Submission for Abbreviated New Drug Application; $750 Million Market for Suicidal Depression Market Awaits Preservative-Free IV Ketamine: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
December 02, 2025
Via
Get News
Tickers
NRXP
Exposures
Product Safety
Beyond the Headlines: Understanding the Forces Driving Today's Stock Market
December 02, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Climate Change
Economy
Tickers
AMZN
GOOGL
MSFT
NVDA
TGT
WMT
Exposures
Artificial Intelligence
Climate
Economy
United Natural Foods (UNFI) Beats Earnings Estimates, Signaling Resilience in Supermarket Sector
December 02, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Economy
Tickers
AMZN
CORE
KR
NGVC
SFM
SPTN
Exposures
Artificial Intelligence
Financial
Interest Rates
InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Announces FDA Receipt of ANDA for KETAFREE With July 2026 Review Goal Date
December 02, 2025
Via
Investor Brand Network
Tickers
NRXP
Exposures
Product Safety
Envoy Medical Announces the Grant of Its 40th U.S. Patent
December 02, 2025
Via
Newsfile
Topics
Intellectual Property
Tickers
ASX:COH
COCH
Exposures
Intellectual Property
Product Safety
Stock Index Futures Gain as Investors Recover Risk Appetite
December 02, 2025
Via
Barchart.com
Topics
Death
Economy
Stocks
Tickers
COIN
GS
NVDA
UBS
Exposures
COVID-19
Death
Economy
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.